Updates on 503A Compounding: Legal and Regulatory Developmen

Part 1 of this 2-part series examines USP <797> and <795> revisions for sterile and nonsterile compounding, veterinary compounding, FDA inspections of 503A pharmacies, and the interstate distribution of compounded prescriptions post Wellness Pharmacy v. FDA.

Related Keywords

California , United States , Frier Levitt , Martham Rumore , Drug Evaluation Research , Office Of Compliance , Wellness Pharmacy Inc , Wellness Pharmacy , Insanitary Conditions , Distribution Post Wellness Pharmacy , Administrative Procedures , Compounding Facilities , Drug Evaluation , Animal Drugs , Bulk Drug , Veterinary Medicine , Inspectional Activities Related , Animal Drugs From Bulk Drug , Legally Marketed Unapproved New Animal Drugs , Minor Species , Period Before , Drug Administration Intends , Begin Enforcing , Out Of Sate Distribution , Compounded Human Drug Products ,